Keywords: shire, makes, progress, sampatrilat, pharmaceuticals, reported, promising

Shire makes progress with sampatrilat

Article | 19 December 2000

Shire Pharmaceuticals has reported promising preclinical data with itsdual neutral endopeptidase/ angiotensin-converting enzyme inhibitor, sampatrilat, and says it has made ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Shire

Bristol-Myers Squibb

Pfizer

Go to company listing

Related Drugs

Nystatin

Go to drug listing